Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($) segment	Dec. 31, 2024 USD ($)
Segment Reporting [Abstract]
Number of operating segments | segment	1
Number of reportable segments | segment	1
Segment Reporting Information [Line Items]
Research and collaboration revenue	$ 3,498	$ 652
Less: Significant segment expenses
Impairment of right-of-use asset	494	0
Net loss	(80,403)	(51,791)
R&D
Segment Reporting Information [Line Items]
Research and collaboration revenue	3,498	652
Less: Significant segment expenses
Personnel-related expenses	20,506	20,299
Clinical and preclinical expenses	17,322	18,049
Facilities-related and overhead	7,734	7,625
Professional and consulting fees	7,660	5,984
Corporate expenses	1,678	1,175
Impairment of right-of-use asset	494	0
Travel and entertainment	659	608
Plus: Other segment (loss) income	(27,848)	1,297
Net loss	$ (80,403)	$ (51,791)